Abstract A 55-year-old female with standard risk AML in second CR received an allogenic transplant from an HLA-matched sibling, using a nonmyeloablative conditioning regimen (NMST). On day +139, she rejected her graft with autologous reconstitution. She received a second NMST from a different HLA-matched sibling with an identical conditioning regimen and immunosuppression. On day +110, she rejected the second graft, with autologous reconstitution with blasts. She received a third allograft from the first sibling with a myeloablative busulfan-based conditioning regimen. She is now day +270, in CR, with full donor chimerism.
|Autori interni:||PAPINESCHI, FEDERICO|
|Autori:||PAPINESCHI F; BUCALOSSI; A.; CAPOCHIANI; E; BENEDETTI; E; BRAMANTI; E|
|Titolo:||Recombinant 2a Interferon and Polycythemia Vera: clinical results and biological evaluation by means of Fourier-Transform Infrared Microspectroscopy|
|Anno del prodotto:||1994|
|Appare nelle tipologie:||1.1 Articolo in rivista|